side effects of tirzepatide with b12 Compounded Weight Loss Program | GLP-1 Treatment Tirzepatide Side Effects: What Patients

Insights:Gastroenterol

Vincent is proud to be Billings' first hospital, caring for generations in our community

Frontiers in Oncology, 8

How It Compares to Other Treatments To comprehend the advancement in this therapy, it is first useful to provide a point of reference with other similar drugs in this category: Semaglutide (Ozempic, Wegovy): GLP-1 Target Average weight loss: ~15% Tirzepatide (Mounjaro): GLP-1 + GIP Targets Average weight loss: ~20% to 22% Retatrutide: GLP-1 + GIP + Glucagon Targets Average weight loss of 24% in clinical trials As a result, triple-agonist therapy can be an extremely promising new option for medically induced weight loss

Non-caloric supplements (electrolytes, certain nootropics, melatonin) are generally safe, but avoid anything containing amino acids, BCAAs, or sweeteners